Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › levomilnacipran

levomilnacipran

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of levomilnacipran

4 trials tracked of levomilnacipran: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 40 citations.

4Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 2 Other / NA 1
  1. Phase 4 Trial of Levomilnacipran in Geriatric Depression Completed · 40 cited
  2. Phase 3 Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder Completed · 6 cited
  3. Phase 3 Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD Completed
  4. N/A Novel Medication as a Potential Smoking Cessation Aid Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Desipramine shows large effect in adolescent MDD while other antidepressants show no significant difference
Psychiatry Meta-analysis
Desipramine shows large effect in adolescent MDD while other antidepressants show no significant difference Analysis shows only one antidepressant outperformed placebo for teen depression
This systematic review and network meta-analysis evaluated five antidepressants for adolescent MDD. While desipramine showed a large effect …
New data reveals that while most common antidepressants showed no significant difference from a placebo for teens with depression.
Frontiers Aug 28, 2026